The Inability To Detect Changes In Skin Temperature May Contribute To The Poor Sleep Of Older Adults Who Have Insomnia

The Inability To Detect Changes In Skin Temperature May Contribute To The Poor Sleep Of Older Adults Who Have Insomnia
A study in the Sept. 1 issue of the journal Sleep shows that the subjective interpretation of temperature change is decreased in older adults, particularly those who suffer from insomnia. The study is the first to find pronounced attenuation of subjective thermosensitivity in elderly insomniacs within the small range of normal bed temperatures.

Children With TVs In Their Room Sleep Less
Middle school children who have a television or computer in their room sleep less during the school year, watch more TV, play more computer games and surf the net more than their peers who don't - reveals joint research conducted by the University of Haifa and Jezreel Valley College. The research, conducted by Prof. Yael Latzer and Dr. Tamar Shochat of the University of Haifa and Prof.

Put sleep on back-to-school checklist, experts say
For teenagers, summer often means staying up to all hours of the night and sleeping in the next day. That will, or should, all come to an end shortly as students head back to school, experts advise.

Chronic Insomnia Linked To Reversible Cognitive Deficits Without Changes In Behavior
A neuroimaging study in the Sept. 1 issue of the journal Sleep is the first to find that cognitive processes related to verbal fluency are compromised in people with insomnia despite the absence of a behavioral deficit. These specific brain function alterations can be reversed, however, through non-pharmacological treatment with sleep therapy.

ENT Doctors Showcase New Research In Chicago, Sept. 21-24
The 2008 Annual Meeting & OTO EXPO of the American Academy of Otolaryngology - Head and Neck Surgery Foundation (AAO-HNSF) will convene September 21 - 24, 2008 in Chicago. The meeting is the world's largest gathering of otolaryngologists and a forum for renowned guests.

LUNESTA(R) Next-Day Function And Discontinuation Data From A Long-Term 12-Week Study In Elderly Patients Presented At ECNP
Sepracor Inc. (Nasdaq: SEPR) announced the presentation of LUNESTA ® brand eszopiclone Phase IV study data at the 21st European College of Neuropsychopharmacology (ECNP) Congress in Barcelona. The poster presentations reflected results from a 12-week, double-blind, randomized safety and efficacy study of 388 elderly patients (65-85 years of age) who were administered either LUNESTA 2 mg or placebo nightly.